The CD4+ T cells of MS patients showed a trend toward a higher maximum VAF, corresponding to a possibly larger clonal size, both for all possibly damaging variants and for possibly damaging variants in expressed genes (p = 0.048, Figures 2F, I), although this does not survive multiple testing correction. Here, CD4 is linked to myeloid sarcoma.